Governor Kathy Hochul celebrated the opening of the Roswell Park GMP Engineering and Cell Manufacturing Facility, New York’s first cell and gene therapy hub, located at Roswell Park Comprehensive Cancer Center in Buffalo. The $98 million facility will create new jobs, help to support the research and development of life-saving cell and gene therapies at Roswell, significantly grow its well-established research capabilities, and establish Roswell as one of the premier cell therapy discovery and development institutions in the nation. The expansion also realizes Governor Hochul’s 2023 State of the State commitment to bolster the state’s leadership in the fast-growing CGT sector through establishment of an Upstate cell and gene therapy hub to catalyze its growth in western NY. The GEM facility meets U.S. FDA Good Manufacturing Practice standards for manufacture of clinical cell therapy products, positioning the Roswell Park team to be a multifaceted resource for patients, care teams, researchers, and industry collaborators. See pictures of the Roswell GEM here.
“Given cell and gene therapy’s potential to be the most transformative therapeutic advance in decades, New York’s investment in this fast-growing sector solidifies our state’s future as a leader and highly desired partner in cell therapy research, development and manufacturing,” Governor Hochul said. “This opening of the first of two CGT hubs in New York State will attract life science companies, accelerate CGT research in life science companies and our premier academic institutions, and create 21st century jobs, while offering hope to generations of New Yorkers and others who rely on the creation of these cutting-edge treatments.”
